Skip to main content
Thorax logoLink to Thorax
. 1984 Feb;39(2):159–160. doi: 10.1136/thx.39.2.159

Lung angiotensin converting enzyme activity in monocrotaline pulmonary hypertension.

P M Keane, J M Kay
PMCID: PMC459746  PMID: 6322375

Full text

PDF
159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Huxtable R., Ciaramitaro D., Eisenstein D. The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium. Mol Pharmacol. 1978 Nov;14(6):1189–1203. [PubMed] [Google Scholar]
  2. Lafranconi W. M., Huxtable R. J. Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline. Thorax. 1983 Apr;38(4):307–309. doi: 10.1136/thx.38.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES